Showing results (1591-1600 of 6,415) with videos related to

Sort By:
Pageof 642
Clinical Cardiology|July 1, 1986
Incidence of systemic thromboembolic lesions in acute myocardial infarctionM Puletti, E Cusmano, M G Testa, et al.
Clinical Cardiology|July 1, 1986
Eosinophilic endomyocardiopathyP J Kudenchuk, J D Hosenpud, S Fletcher
Clinical Cardiology|August 1, 1986
Clinical studies on diabetic myocardial disease using exercise testing with myocardial scintigraphy and endomyocardial biopsyA Genda, S Mizuno, S Nunoda, et al.
Clinical Cardiology|October 19, 2020
Ablation of paroxysmal and persistent atrial fibrillation in the very elderly real-world data on safety and efficacyKevin Willy, Kristina Wasmer, Dirk G Dechering, et al.
Clinical Cardiology|March 20, 2020
Myocardial fibrosis in athletes-Current perspectiveŁukasz A Małek, Chiara Bucciarelli-Ducci
Clinical Cardiology|February 28, 2020
Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillationBenjamin Miao, Adrian V Hernandez, Yuani M Roman, et al.
Clinical Cardiology|September 1, 1986
Two-dimensional echocardiographic evaluation of ventricular asynergy induced by dipyridamole: correlation with thallium scanningN Ferrara, D Bonaduce, D Leosco, et al.
Clinical Cardiology|December 29, 2020
Acquired von Willebrand syndrome and factor VIII in patients with moderate to severe mitral regurgitation undergoing transcatheter mitral valve repairChristine Meindl, Michael Paulus, Theresia Koller, et al.
Clinical Cardiology|December 29, 2020
General anesthesia is not superior to sedation in clinical outcome and cost-effectiveness for ablation of persistent atrial fibrillationZhengyan Wang, Lihong Jia, Tieying Shi, et al.
Clinical Cardiology|June 11, 2021
Glycoprotein IIb/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre-treated with newer P2Y12 inhibitorsKatrien Blanchart, Thibaut Heudel, Pierre Ardouin, et al.
Pageof 642